{"GFI": {"score": "7/7 5/7", "date": "2025-06-05", "exchange": "NYQ", "currency": "USD", "summary": "Gold Fields Limited operates as a gold producer with reserves and resources in Australia, South Africa, Ghana, Peru, Chile, and Canada. It also explores for copper and silver deposits. Gold Fields Limited was founded in 1887 and is based in Sandton, South Africa.", "gain": -0.029110936270653105}, "ALNY": {"score": "6/7 6/7", "date": "2025-06-05", "exchange": "NMS", "currency": "USD", "summary": "Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference. It offers ONPATTRO and AMVUTTRA for hereditary transthyretin-mediated amyloidosis; GIVLAARI for acute hepatic porphyria; OXLUMO for primary hyperoxaluria type 1; and Leqvio for hypercholesterolemia. It also develops vutrisiran, which is in phase III clinical trial for transthyretin amyloidosis (ATTR) with cardiomyopathy; Nucresiran that is in phase I clinical trial for ATTR amyloidosis; Fitusiran, which is in phase III clinical trial for hemophilia; cemdisiran that is in phase III clinical trial for Myasthenia Gravis and paroxysmal nocturnal hemoglobinuria, and geographic atrophy; and ALN-6400, which is in phase I clinical trial for bleeding disorders. In addition, the company is also developing Zilebesiran, which is in phase II clinical trial for hypertension; Rapirosiran that is in phase II clinical trial for Metabolic dysfunction-associated steatohepatitis; ALN-4324, which is in phase I clinical trial for type 2 diabetes mellitus; ALN-PNP that is in phase I clinical trial for non-alcoholic fatty liver disease; ALN-APOC3, which is in phase I clinical trial for dyslipidemia; Mivelsiran that is in phase II clinical trial for cerebral amyloid angiopathy, and phase I clinical trial for Alzheimer's disease; and ALN-HTT02 that is in phase I clinical trial for Huntington's disease. Further, it develops ALN-SOD, which is in phase II clinical trial for SOD1 Amyotrophic lateral sclerosis; Elebsiran that is in phase II clinical trial for Hepatitis B and D virus infections; ALN-BCAT that is in phase I clinical trial for hepatocellular carcinoma; and ALN-ANG3. It has collaborations with Regeneron Pharmaceuticals, Inc.; Roche Holding AG; Regeneron Pharmaceuticals, Inc.; Sanofi S.A.; Novartis AG; PeptiDream, Inc; Dicerna Pharmaceuticals, Inc.; and Ionis Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.", "gain": 0.06756493506493508}, "PAC": {"score": "7/7 6/7", "date": "2025-06-05", "exchange": "NYQ", "currency": "USD", "summary": "Grupo Aeroportuario del Pac\u00edfico, S.A.B. de C.V., together with its subsidiaries, develops, operates, and manages airports in Mexico and Jamaica. The company operates twelve international airports in Guadalajara and Tijuana areas, Mexico; and two international airports in Montego Bay, Jamaica. It also offers aeronautical services, such as passenger, aircraft landing, parking charges, leasing of space to these airlines, airport security and passenger walkway, and airport bus; complementary services, including baggage handling, catering, aircraft maintenance and repair, and fuel; cargo handling; and ground transportation services. In addition, the company provides non-aeronautical services, such as redesigning and modernizing terminal spaces and developing new projects; telephone and internet services; and ground handling services under the brand Primesky, as well as advertising services. Further, it engages in commercial activities comprising leasing space in terminals to airlines and other service providers; retail stores, such as souvenir and gift shops, fashion and footwear stores, pharmacies, jewelry, electronics, cosmetics, and others; and various food and beverage services, as well as leasing space to car rental service companies, including parking spots, lots, and car rental reservation booths; and leasing space to timeshare developers, financial service providers, communications, and to operators of duty-free stores. Additionally, the company operates parking facilities; VIP lounges; convenience stores; and vending machines. The company was incorporated in 1998 and is headquartered in Guadalajara, Mexico.", "gain": -0.051465604879701816}, "PAAS": {"score": "7/7 5/7", "date": "2025-06-05", "exchange": "NYQ", "currency": "USD", "summary": "Pan American Silver Corp. engages in the exploration, mine development, extraction, processing, refining, and reclamation of mines in Canada, Mexico, Peru, Bolivia, Argentina, Chile, and Brazil. It explores for silver, gold, zinc, lead, and copper deposits. The company was formerly known as Pan American Minerals Corp. and changed its name to Pan American Silver Corp. in April 1995. Pan American Silver Corp. was incorporated in 1979 and is headquartered in Vancouver, Canada.", "gain": 0.01888111888111885}, "HEI": {"score": "6/7 6/7", "date": "2025-06-05", "exchange": "NYQ", "currency": "USD", "summary": "HEICO Corporation, through its subsidiaries, designs, manufactures, and sells aerospace, defense, and electronic related products and services in the United States and internationally. It operates in two segments Flight Support Group (FSG) and Electronic Technologies Group (ETG). The FSG segment provides jet engine and aircraft component replacement parts; thermal insulation blankets and parts; renewable/reusable insulation systems; and specialty components and assemblies. This segment also distributes hydraulic, pneumatic, structural, interconnect, mechanical, and electro-mechanical components for the commercial, regional, and general aviation markets; and offers repair and overhaul services for jet engine and aircraft component parts, avionics, instruments, composites, and flight surfaces of commercial aircraft, as well as for avionics and navigation systems, subcomponents, and other instruments utilized on military aircraft. The ETG segment provides electro-optical infrared simulation and test equipment; electro-optical laser products; electro-optical, microwave, and other power equipment; electromagnetic and radio frequency (RF) interference shielding and suppression filters; power electronics; power conversion and interface products; interconnection devices; and underwater locator and emergency locator transmission beacons. This segment also offers traveling wave tube amplifiers and microwave power modules; memory products and specialty semiconductors; harsh environment connectivity products and custom molded cable assemblies; RF and microwave products; communications and electronic intercept receivers and tuners; self-sealing auxiliary fuel systems; active antenna systems and airborne antennas; nuclear radiation detectors; silicone products; power amplifiers; ceramic-to-metal feedthroughs and connectors; technical surveillance countermeasures equipment; RF receivers and sources; embedded computing solutions; test sockets and adapters; radiation assurance services; and electronic components and rotary joint assemblies. The company was incorporated in 1957 and is headquartered in Hollywood, Florida.", "gain": 0.07544098594824449}, "CCEP": {"score": "7/7 6/7", "date": "2025-06-05", "exchange": "NMS", "currency": "USD", "summary": "Coca-Cola Europacific Partners PLC, together with its subsidiaries, produces, distributes, and sells a range of non-alcoholic ready to drink beverages. It offers flavours, mixers, and energy drinks; soft drinks, water, enhanced water, and isotonic drinks; and tea and coffee, juices, and other drinks. The company provides its products under the Coca-Cola Original Taste, Coca-Cola Zero Sugar, Diet Coke, Sprite, Sprite Zero Sugar, Fanta, Fanta Zero Sugar, Monster Energy, A&W, Absolut Vodka & SPRITE, Ades, Appletiser, aquaBona, Aquarius, BACARD\u00cd Mixed with Coca-Cola RTD, Barista Bros, Bonaqua, BURN, Deep Spring, Dr Pepper, Dr Pepper Zero Sugar, Feral Brewing Co, Fuze Tea, Giancarlo Coffee, GLACEAU smartwater, Grinders, HALO, Jack Daniel's and Coca-Cola ready-to-drink, Kristal, L&P, MER, Minute Maid, most, Mother, Mount Franklin, Nordic Mist, Nutriboost, Oasis, Pulpy, pump, pumped, Reign, Rekorderlig Cider, Relentless, Royal, Royal Bliss, RUM Co. of Fiji, Schweppes, Schweppes Mix, SOCO, URGE, Vilas del Turb\u00f3n, Voyage, Wilkins Pure, and Zephyr Coffee Co brands. It is also involved in the bottling and other operations. The company was formerly known as Coca-Cola European Partners plc and changed its name to Coca-Cola Europacific Partners PLC in May 2021. The company was founded in 1904 and is based in Uxbridge, the United Kingdom.", "gain": 0.0871549663116715}, "SNN": {"score": "6/7 5/7", "date": "2025-06-05", "exchange": "NYQ", "currency": "USD", "summary": "Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.", "gain": 0.045214521452145245}}